Streetbeat News

Regulatory

WBUY

Webuy Global Ltd. (NASDAQ:WBUY) has received an extension of 180 days, until January 21, 2025, to comply with Nasdaq's minimum bid price requirement of $1.00 per share.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:35 pm

SPY

The USA Core PCE Price Index (YoY) for June came in at 2.6%, slightly above the estimated 2.5% and matching the prior month's figure of 2.6%.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:30 pm

PFC

Trading halt status was updated at 8:25:00 AM ET, with details on quotation resumption and news resumption times.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:25 pm

CVM

CEL-SCI Corporation (NYSE:CVM) reported positive results from a bias analysis for its Phase 3 study of Multikine, a cancer immunotherapy for head and neck cancer. The analysis showed no bias, supporting the efficacy results, and Multikine cut the 5-year risk of death by half compared to control.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:24 pm

COUR

CREV

WINT

Market-Moving News for July 26th: Carbon Revolution (CREV) teams up with GM to provide carbon fiber wheels for the Chevrolet Corvette ZR1, Windtree Therapeutics (WINT) withdraws its registration statement, and Coursera (COUR) shares rise after beating Q2 earnings estimates.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:22 pm

CLLS

Cellectis shares are trading higher after the company announced the FDA granted orphan drug and rare pediatric designation disease to UCART22.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:20 pm

BABA

META

NVDA

Alibaba and Tencent have integrated Meta's latest AI model, Llama 3.1, into their cloud services. This move comes amid strained U.S.-China relations and advanced semiconductor sanctions. Alibaba's stock has been under pressure, losing over 22% in the last 12 months.

Portfolio Pulse from Anusuya Lahiri

July 26, 2024 | 12:15 pm

PFC

Trading for PFC was halted at 8:05:00 a.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 12:05 pm

MEDS

Trading for the stock MEDS has been halted as of 7:55:00 a.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 11:55 am

BIIB

Biogen shares are trading lower after the European Medicines Agency adopted a negative opinion on the Marketing Authorization Approval for lecanemab.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 11:44 am